How tirzepatide addresses cardiovascular risk The Jorge 2026 study demonstrated that GLP-1 receptor agonists were associated with significantly lower risks of major adverse cardiovascular events in lupus patients compared to DPP-4 inhibitors
The results showed better outcomes in some patients, indicating potential efficacy and paving the way for future large-scale studies on neuroprotection
If you are smoking while taking Ozempic and are concerned about any symptoms or side effects that you are experiencing, be sure to consult with your medical team as soon as possible
After 28 days, the antimicrobial effectiveness of the 0.9% benzyl alcohol begins to decline, and the cumulative risk from repeated needle punctures increases
By enhancing this natural process, Ozempic assists in maintaining stable glucose levels
August 19, 2025: Judge Clarifies Tests Needed to Prove Gastroparesis From Mounjaro People who filed lawsuits claiming Mounjaro caused them to develop gastroparesis now have clarification on how to prove their diagnoses
